MoonLake Immunotherapeutics (MLTX)
Latest MLTX Insider Trades
About MoonLake Immunotherapeutics (MLTX)
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.
- ZUG, V8
- 130
- 2022
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 14 | 470,349 | $9.34M |
| Grant or award | 5 | 110,975 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
MLTX Insider Transactions (Form 4)
5334 Form 4 filings on record, the earliest from Oct 8, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Kristian Reich - Officer | Open-market sale | Class A ordinary shares, par value $0.0001 per share |
Recent MLTX Form 8-K Filings
5Recent MLTX Form 144 Notices of Proposed Sale
3A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - |
MLTX Insider Trading - FAQ
What is the latest insider trade for MLTX?
MoonLake Immunotherapeutics (MLTX) had 14 insider filings in the last 90 days, with the most recent on 2026-07-29. The full record for MLTX runs to 34 Form 4 filings, the earliest from 2024-10-08. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying MLTX stock?
No insider purchases of MLTX were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling MLTX stock?
14 insider sales of MLTX were filed in the last 90 days, totaling $9.34M.
Where can I see MLTX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks MLTX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow MLTX insider buys?
Create a free InsiderAlpha account and press Watch on this page to add MLTX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Kristian Reich view on EDGAR
- - Kristian Reich view on EDGAR
- - Kristian Reich view on EDGAR
- - Kristian Reich view on EDGAR
- - da Silva Jorge Santos view on EDGAR
- - da Silva Jorge Santos view on EDGAR
- - Matthias Bodenstedt view on EDGAR
- - BVF PARTNERS L P view on EDGAR
- - Matthias Bodenstedt view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where MLTX's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track MLTX insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
